This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Xencor, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Pankaj Seth: Innovator in Cancer Treatment
Introduction
Pankaj Seth is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of cancer treatment through his innovative work on antibodies. With a total of 2 patents, Seth is recognized for his advancements in therapeutic methods targeting PSMA-associated cancers.
Latest Patents
Seth's latest patents focus on novel anti-CD28×anti-PSMA antibodies. These antibodies are designed to agonistically bind to CD28 costimulatory molecules on T cells and PSMA on tumor cells. This unique binding mechanism selectively enhances anti-tumor activity at tumor sites while minimizing peripheral toxicity. The antibodies are particularly useful when combined with other anti-cancer therapies, such as anti-CD3×anti-PSMA antibodies, for the treatment of prostate cancers.
Career Highlights
Pankaj Seth is currently associated with Xencor, Inc., where he continues to develop innovative solutions for cancer treatment. His work has positioned him as a key figure in the research and development of effective cancer therapies.
Collaborations
Seth collaborates with esteemed colleagues, including John R Desjarlais and Gregory L Moore, to further enhance the impact of his research in the field of oncology.
Conclusion
Pankaj Seth's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile